Assessment and Treat Neglect Patients With a VR Application

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversiteit Antwerpen

About this trial

The objective of this project is to investigate the effectiveness of neglect training in our self-developed VR application "SpatialSense". The investigators aim to reach the following goals:

i. Compare conventional neglect therapy for neglect training with SpatialSense to evaluate the impacts on neglect recovery to see whether the VR therapy improves the clinical outcomes, such as balance recovery, perception of verticality, quality of life, independence in daily activities, and cognitive impairment, after rehabilitation training.

ii. Analyze and compare the search strategies employed by stroke patients with VSN and those without VSN during the execution of the search task with SpatialSense to summarize typical visual scanning strategies for facilitation, rehabilitation training, and improving the transfer effect in daily activities.

The experimental group will receive both conventional OT and PT treatment, but 3 days a week, half an hour of conventional treatment will be replaced by treatment with SpatialSense software. The control group will receive their regular dose-matched conventional OT and PT sessions without interference. The experimental group will receive SpatialSense training 3 times a week for a consecutive 4 weeks (12 sessions in total of 30 minutes).

Eligibility criteria

Qualifiers

Age 18 years or older

Able to provide informed consent

have had a hemispheric stroke

Disqualifiers

Have a severe comorbid psychiatric (E.g. psychotic symptoms) disorder

Have a premorbid neurodegenerative disease (E.g. Alzheimer's dementia, vascular dementia)

Have severe written language comprehension deficits

Have a medical implant, such as a cochlear implant or a pacemaker

Trial design

Treatments tested in this trial

  • Virtual reality training
  • physiotherapy and occupational therapy
  • Assessment

Treatment groups

30 Participants
are divided into 3 treatment groups

Sponsors and collaborators